Interestingly, necroptosis has also been implicated in anti-tumor immunity, with research suggesting that RIPK3 plays a regulatory role in the activity of natural killer T (NKT) cells, enhancing NKT-mediated anti-tumor responses (53). The gene discussed is RIPK3; the disease is neoplasm.